Brain-derived neurotrophic factor in neuroimmunology: Lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models

Archivum Immunologiae et Therapiae Experimentalis

Volumn 61, Issue 2, 2013, Pages 95-105

  Lühder, Fred ^a   Gold, Ralf ^b   Flügel, Alexander ^a   Linker, Ralf A ^c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Brain derived neurotropic factor (BDNF); Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis (MS); Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN RECEPTOR P75; TYROSINE KINASE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; BINDING AFFINITY; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; DEMYELINATING DISEASE; GENETIC VARIABILITY; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROIMMUNOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; AUTOANTIGENS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MICE; MULTIPLE SCLEROSIS;

EID: 84879461875     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0211-0     Document Type: Review

References (131)

1. Aharoni R, Kayhan B, Eilam R et al (2003) Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci USA 100:14157-14162 (Pubitemid 37499207)
2. Azoulay D, Vachapova V, Shihman B et al (2005) Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate. J Neuroimmunol 167:215-218 (Pubitemid 41242305)
3. Azoulay D, Urshansky N, Karni A (2008) Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J Neuroimmunol 195:186-193
4. Balanza-Martinez V, Fries GR, Colpo GD et al (2011) Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 11:1029-1047
5. Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549-553
6. Baseri B, Choi JJ, Deffieux T et al (2012) Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles. Phys Med Biol 57:N65-N81
7. Besser M, Wank R (1999) Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 162:6303-6306 (Pubitemid 29309346)
8. Bjartmar C, Kinkel RP, Kidd G et al (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57:1248-1252 (Pubitemid 32947384)
9. Blanco Y, Saiz A, Costa M et al (2005) Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis. Neurosci Lett 380:122-126 (Pubitemid 40602341)
10. Bratke K, Maruschke L, Darowski M et al (2007) A role for the neurotrophin receptor TrkB on maturing dendritic cells. J Neuroimmunol 189:88-94 (Pubitemid 47379437)
11. Buck D, Hemmer B (2011) Treatment of multiple sclerosis: current concepts and future perspectives. J Neurol 258:1747-1762
12. Carroll P, Lewin GR, Koltzenburg M et al (1998) A role for BDNF in mechanosensation. Nat Neurosci 1:42-46 (Pubitemid 128652640)
13. Cerasa A, Tongiorgi E, Fera F et al (2010) The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav Brain Res 207:377-386
14. Chapleau CA, Pozzo-Miller L (2012) Divergent roles of p75NTR and Trk receptors in BDNF's effects on dendritic spine density and morphology. Neural Plast 2012:578057
15. Chen M, Valenzuela RM, Dhib-Jalbut S (2003) Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor. J Neurol Sci 215:37-44 (Pubitemid 37279143)
16. Colombo E, Cordiglieri C, Melli G et al (2012) Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J Exp Med 209:521-535
17. Comini-Frota ER, Rodrigues DH, Miranda EC et al (2012) Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis. Braz J Med Biol Res 45:68-71
18. Cordeira J, Rios M (2011) Weighing in the role of BDNF in the central control of eating behavior. Mol Neurobiol 44:441-448
19. De Santi L, Annunziata P, Sessa E et al (2009a) Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neurol Sci 287:17-26
20. De Santi L, Cantalupo L, Tassi M et al (2009b) Higher expression of BDNF receptor gp145trkB is associated with lower apoptosis intensity in T cell lines in multiple sclerosis. J Neurol Sci 277:65-70
21. De Santi L, Polimeni G, Cuzzocrea S et al (2011) Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment. Curr Med Chem 18:1775-1784
22. Dinacci D, Tessitore A, Russo A et al (2011) BDNF Val66Met polymorphism and brain volumes in multiple sclerosis. Neurol Sci 32:117-123
23. Dittrich F, Ochs G, Grosse-Wilde A et al (1996) Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp Neurol 141:225-239 (Pubitemid 26338349)
24. Durany N, Michel T, Zochling R et al (2001) Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52:79-86 (Pubitemid 32947050)
25. Egan MF, Kojima M, Callicott JH et al (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269 (Pubitemid 36144114)
26. Eide FF, Vining ER, Eide BL et al (1996) Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci 16:3123-3129 (Pubitemid 26142348)
27. Ernfors P, Lee KF, Jaenisch R (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147-150 (Pubitemid 24101525)
28. Fauchais AL, Lalloue F, Lise MC et al (2008) Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol 181:3027-3038
29. Favalli G, Li J, Belmonte-de-Abreu P, Wong AH et al (2012) The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 46:1-11
30. Felts PA, Smith KJ, Gregson NA et al (2002) Brain-derived neurotrophic factor in experimental autoimmune neuritis. J Neuroimmunol 124:62-69 (Pubitemid 34212011)
31. Fernandes BS, Gama CS, Cereser KM et al (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45:995-1004
32. Finkbeiner S, Tavazoie SF, Maloratsky A et al (1997) CREB: a major mediator of neuronal neurotrophin responses. Neuron 19:1031-1047 (Pubitemid 27512364)
33. Flügel A, Matsumuro K, Neumann H et al (2001) Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur J Immunol 31:11-22
34. Frota ER, Rodrigues DH, Donadi EA et al (2009) Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse. Neurosci Lett 460:130-132
35. Fujimura H, Altar CA, Chen R et al (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87:728-734 (Pubitemid 34302963)
36. Gold SM, Schulz KH, Hartmann S et al (2003) Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J Neuroimmunol 138:99-105 (Pubitemid 36566423)
37. Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953-1971 (Pubitemid 44289062)
38. Gonul AS, Akdeniz F, Taneli F et al (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255:381-386 (Pubitemid 43029827)
39. Grace AA (2012) Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 62:1342-1348
40. Grande I, Fries GR, Kunz M et al (2010) The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 7:243-250
41. Green MJ, Matheson SL, Shepherd A et al (2011) Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 16:960-972
42. Hamamcioglu K, Reder AT (2007) Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Mult Scler 13:459-470 (Pubitemid 46796506)
43. Hashimoto T, Bergen SE, Nguyen QL et al (2005) Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 25:372-383 (Pubitemid 40105607)
44. Herrero-Herranz E, Pardo LA, Gold R et al (2008) Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis 30:162-173
45. Herz J, Zipp F, Siffrin V (2010) Neurodegeneration in autoimmune CNS inflammation. Exp Neurol 225:9-17
46. Hohlfeld R, Kerschensteiner M, Stadelmann C et al (2000) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 107:161-166 (Pubitemid 30347422)
47. Howells DW, Porritt MJ, Wong JY et al (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol 166:127-135
48. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736 (Pubitemid 32695243)
49. Iughetti L, Casarosa E, Predieri B et al (2011) Plasma brain-derived neurotrophic factor concentrations in children and adolescents. Neuropeptides 45:205-211
50. Javeri S, Rodi M, Tary-Lehmann M et al (2010) Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis. Clin Immunol 137:181-189
51. Jones JL, Anderson JM, Phuah CL et al (2010) Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Brain 133:2232-2247
52. Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391 (Pubitemid 30389307)
53. Karege F, Perret G, Bondolfi G et al (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148 (Pubitemid 34258493)
54. Karege F, Bondolfi G, Gervasoni N et al (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57:1068-1072 (Pubitemid 40613035)
55. Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290-1300 (Pubitemid 30151025)
56. Kerschensteiner M, Gallmeier E, Behrens L et al (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-870 (Pubitemid 29189691)
57. Kishino A, Katayama N, Ishige Y et al (2001) Analysis of effects and pharmacokinetics of subcutaneously administered BDNF. NeuroReport 12:1067-1072 (Pubitemid 32281476)
58. Korte M, Carroll P, Wolf E et al (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-8860
59. Koshimizu H, Kiyosue K, Hara T et al (2009) Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol Brain 2:27
60. Kramer R, Zhang YP, Gehrmann J et al (1995) Gene-transfer through the blood-nerve barrier - ngf-engineered neuritogenic T-lymphocytes attenuate experimental autoimmune neuritis. Nat Med 1:1162-1166
61. Kruse N, Cetin S, Chan A et al (2007) Differential expression of BDNF mRNA splice variants in mouse brain and immune cells. J Neuroimmunol 182:13-21 (Pubitemid 46026702)
62. Laurenzi MA, Beccari T, Stenke L et al (1998) Expression of mRNA encoding neurotrophins and neurotrophin receptors in human granulocytes and bone marrow cells-enhanced neurotrophin-4 expression induced by LTB4. J Leukoc Biol 64:228-234 (Pubitemid 28354986)
63. Lee R, Kermani P, Teng KK et al (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945-1948 (Pubitemid 33101595)
64. Lee DH, Geyer E, Flach AC et al (2012) Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination. Acta Neuropathol 123:247-258
65. Lewin GR, Barde YA (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317 (Pubitemid 26080831)
66. Liguori M, Fera F, Patitucci A et al (2009) A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis. Brain Res 1256:123-128
67. Linker RA, Maurer M, Gaupp S et al (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8:620-624 (Pubitemid 34633441)
68. Linker RA, Kruse N, Israel S et al (2008) Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation. J Immunol 180:2204-2213
69. Linker R, Gold R, Lühder F (2009) Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Crit Rev Immunol 29:43-68
70. Linker RA, Lee DH, Demir S et al (2010) Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133:2248-2263
71. Lodge DJ, Grace AA (2011) Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci 32:507-513
72. Lommatzsch M, Quarcoo D, Schulte-Herbruggen O et al (2005) Neurotrophins in murine viscera: a dynamic pattern from birth to adulthood. Int J Dev Neurosci 23:495-500 (Pubitemid 41138140)
73. Lommatzsch M, Niewerth A, Klotz J et al (2007) Platelet and plasma BDNF in lower respiratory tract infections of the adult. Respir Med 101:1493-1499 (Pubitemid 46832226)
74. Lovas G, Szilagyi N, Majtenyi K et al (2000) Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123(Pt 2):308-317 (Pubitemid 30055154)
75. Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603-614 (Pubitemid 41059335)
76. Lutton JD, Winston R, Rodman TC (2004) Multiple sclerosis: etiological mechanisms and future directions. Exp Biol Med 229:12-20 (Pubitemid 38101674)
77. Makar TK, Trisler D, Eglitis MA et al (2004) Brain-derived neurotrophic factor (BDNF) gene delivery into the CNS using bone marrow cells as vehicles in mice. Neurosci Lett 356:215-219 (Pubitemid 38186690)
78. Makar TK, Trisler D, Sura KT et al (2008) Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis. J Neurol Sci 270:70-76
79. Makar TK, Bever CT, Singh IS et al (2009) Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J Neuroimmunol 210:40-51
80. Maroder M, Bellavia D, Meco D et al (1996) Expression of trkB neurotrophin receptor during T cell development - role of brain-derived neurotrophic factor in immature thymocyte survival. J Immunol 157:2864-2872 (Pubitemid 126450041)
81. Matsumoto T, Rauskolb S, Polack M et al (2008) Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF. Nat Neurosc 11:131-133 (Pubitemid 351170498)
82. Mero IL, Smestad C, Lie BA et al (2012) Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. J Neuroimmunol 244:107-110
83. Miller DH, Barkhof F, Frank JA et al (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676-1695
84. Mizoguchi H, Nakade J, Tachibana M et al (2011) Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus. J Neurosci 31:12963-12971
85. Moalem G, Leibowitz-Amit R, Yoles E et al (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-55 (Pubitemid 29050998)
86. Nakazato M, Hashimoto K, Shimizu E et al (2003) Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54:485-490 (Pubitemid 37289455)
87. Nassenstein C, Braun A, Erpenbeck VJ et al (2003) The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med 198:455-467 (Pubitemid 36976056)
88. Nikic I, Merkler D, Sorbara C, Brinkoetter M et al (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495-499
89. Noble EE, Billington CJ, Kotz CM et al (2011) The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol 300:R1053-R1069
90. Noga O, Peiser M, Altenahr M et al (2007) Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor. Clin Exp Allergy 37:1701-1708 (Pubitemid 47609857)
91. Noseworthy JH, Lucchinetti C, Rodriguez M et al (2000) Multiple sclerosis. N Engl J Med 343:938-952
92. Ochs G, Penn RD, York M et al (2000) A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201-206
93. Patanella AK, Zinno M, Quaranta D et al (2010) Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J Neurosci Res 88:1106-1112
94. Petereit HF, Lindemann H, Schoppe S (2003) Effect of immunomodulatory drugs on in vitro production of brain-derived neurotrophic factor. Mult Scler 9:16-20 (Pubitemid 36253690)
95. Radka SF, Holst PA, Fritsche M et al (1996) Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 709:122-301 (Pubitemid 26063270)
96. Ramasamy DP, Ramanathan M, Cox JL et al (2011) Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: a voxel-based morphometry study. Pathophysiology 18:53-60
97. Rauskolb S, Zagrebelsky M, Dreznjak A et al (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30:1739-1749
98. Rios M, Fan GP, Fekete C et al (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748-1757 (Pubitemid 32939305)
99. Robinson RC, Radziejewski C, Stuart DI et al (1995) Structure of the brain-derived neurotrophic factor neurotrophin 3 heterodimer. Biochemistry 34:4139-4146
100. Robinson M, Buj-Bello A, Davies AM (1996) Paracrine interactions of BDNF involving NGF-dependent embryonic sensory neurons. Mol Cell Neurosci 7:143-151 (Pubitemid 26147292)
101. Rosenfeld RD, Zeni L, Haniu M et al (1995) Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif 6:465-471
102. Sarchielli P, Greco L, Stipa A et al (2002) Brain-derived neurotrophic factor in patients with multiple sclerosis. J Neuroimmunol 132:180-188 (Pubitemid 35333341)
103. Schindowski K, Belarbi K, Buee L (2008) Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 7(suppl 1):43-56
104. Schuhmann B, Dietrich A, Sel S et al (2005) A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol 163:15-23 (Pubitemid 40692945)
105. Schwartz M, Kipnis J (2001) Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med 7:252-258 (Pubitemid 32545521)
106. Scuri M, Samsell L, Piedimonte G (2010) The role of neurotrophins in inflammation and allergy. Inflamm Allergy Drug Targets 9:173-180
107. Shimizu E, Hashimoto K, Okamura N et al (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75 (Pubitemid 36776725)
108. Siffrin V, Vogt J, Radbruch H et al (2010) Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci 33:202-210
109. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747 (Pubitemid 40563183)
110. Stadelmann C, Kerschensteiner M, Misgeld T et al (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75-85 (Pubitemid 34084038)
111. Tam SY, Tsai M, Yamaguchi M et al (1997) Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 90:1807-1820 (Pubitemid 27377290)
112. Thone J, Ellrichmann G, Seubert S et al (2012) Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. Am J Pathol 180:267-274
113. Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269
114. Trapp BD, Peterson J, Ransohoff RM et al (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285 (Pubitemid 28065253)
115. Vega JA, Garcia-Suarez O, Hannestad J et al (2003) Neurotrophins and the immune system. J Anat 203:1-19 (Pubitemid 36889240)
116. Vogt J, Paul F, Aktas O et al (2009) Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol 66:310-322
117. VonDran MW, Clinton-Luke P, Honeywell JZ et al (2010) BDNF ± mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain. Glia 58:848-856
118. VonDran MW, Singh H, Honeywell JZ et al (2011) Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J Neurosci 31:14182-14190
119. Weinstock-Guttman B, Zivadinov R, Tamano-Blanco M et al (2007) Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. J Neuroimmunol 188:167-174 (Pubitemid 47103218)
120. Weinstock-Guttman B, Benedict RH, Tamano-Blanco M et al (2011) The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology 18:43-52
121. Wiesmann C, de Vos AM (2001) Nerve growth factor: structure and function. Cell Mol Life Sci 58:748-759 (Pubitemid 32553032)
122. Winblad B, Messamore E, O'Neill C et al (1993) Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system. Acta Neurol Scand Suppl 149:4-6 (Pubitemid 24027481)
123. Wujek JR, Bjartmar C, Richer E et al (2002) Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61:23-32 (Pubitemid 34027718)
124. Xin J, Mesnard NA, Beahrs T et al (2012) CD4(+) T cell-mediated neuroprotection is independent of T cell-derived BDNF in a mouse facial nerve axotomy model. Brain Behav Immun 26:886-890
125. Yamamoto H, Gurney ME (1990) Human platelets contain brain-derived neurotrophic factor. J Neurosci 10:3469-3478
126. Ye X, Tai W, Zhang D (2012) The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits. Neurobiol Aging 33:1122.e1-10
127. Yeh CM, Huang CC, Hsu KS (2012) Prenatal stress alters hippocampal synaptic plasticity in young rat offspring through preventing the proteolytic conversion of pro-brain-derived neurotrophic factor (BDNF) to mature BDNF. J Physiol 590:991-1010
128. Ziemssen T, Kumpfel T, Klinkert WE et al (2002) Glatiramer acetate-specific T-helper 1-and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain 125:2381-2391 (Pubitemid 35303499)
129. Ziemssen T, Kumpfel T, Schneider H et al (2005) Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: implications for multiple sclerosis therapy. J Neurol Sci 233:109-112 (Pubitemid 40804824)
130. Zivadinov R, Weinstock-Guttman B, Benedict R et al (2007) Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet 16:2659-2668 (Pubitemid 350018508)
131. Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 81:294-330 (Pubitemid 46528643)